Zydus and CSIR-CDRI launch collaborative research for new CKD-induced osteoporosis treatment

Zydus Lifesciences Ltd and CSIR-Central Drug Research Institute (CDRI) have joined forces to develop an innovative drug targeting osteoporosis induced by chronic kidney disease (CKD). ... Read More